FAM204A
gene geneOn this page
Also known as FLJ13188bA319I23.1
Summary
FAM204A (family with sequence similarity 204 member A, HGNC:25794) is a protein-coding gene on chromosome 10q26.11, encoding Protein FAM204A (Q9H8W3).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_022063
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25794 |
| Approved symbol | FAM204A |
| Name | family with sequence similarity 204 member A |
| Location | 10q26.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ13188, bA319I23.1 |
| Ensembl gene | ENSG00000165669 |
| Ensembl biotype | protein_coding |
| Entrez | 63877 |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 26 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000369170, ENST00000369172, ENST00000369183, ENST00000452252, ENST00000467890, ENST00000469758, ENST00000470476, ENST00000487269, ENST00000490048, ENST00000491416, ENST00000885074, ENST00000885075, ENST00000885076, ENST00000885077, ENST00000885078, ENST00000885079, ENST00000885080, ENST00000885081, ENST00000885082, ENST00000885083, ENST00000885084, ENST00000885085, ENST00000885086, ENST00000885087, ENST00000885088, ENST00000935478, ENST00000935479, ENST00000935480, ENST00000935481, ENST00000942972, ENST00000942973, ENST00000942974, ENST00000942975
RefSeq mRNA: 2 — MANE Select: NM_022063
NM_001134672, NM_022063
CCDS: CCDS7605
Canonical transcript exons
ENST00000369183 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001362266 | 118341727 | 118341927 |
| ENSE00001448969 | 118297925 | 118310908 |
| ENSE00003289621 | 118335396 | 118335426 |
| ENSE00003565182 | 118311207 | 118311313 |
| ENSE00003639330 | 118336182 | 118336423 |
| ENSE00003648091 | 118326154 | 118326243 |
| ENSE00003663616 | 118335554 | 118335641 |
| ENSE00003790791 | 118335114 | 118335213 |
| ENSE00003841347 | 118342270 | 118342324 |
Expression profiles
Bgee: expression breadth ubiquitous, 266 present calls, max score 98.85.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.9371 / max 753.4331, expressed in 1801 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 111635 | 32.9371 | 1801 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 98.85 | gold quality |
| monocyte | CL:0000576 | 96.92 | gold quality |
| mononuclear cell | CL:0000842 | 96.49 | gold quality |
| leukocyte | CL:0000738 | 96.26 | gold quality |
| left testis | UBERON:0004533 | 95.42 | gold quality |
| right testis | UBERON:0004534 | 95.20 | gold quality |
| tendon | UBERON:0000043 | 95.01 | gold quality |
| ventricular zone | UBERON:0003053 | 94.85 | gold quality |
| tibial artery | UBERON:0007610 | 94.63 | gold quality |
| gall bladder | UBERON:0002110 | 94.62 | gold quality |
| popliteal artery | UBERON:0002250 | 94.62 | gold quality |
| testis | UBERON:0000473 | 94.52 | gold quality |
| rectum | UBERON:0001052 | 94.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.37 | gold quality |
| mucosa of stomach | UBERON:0001199 | 94.15 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.92 | gold quality |
| cortical plate | UBERON:0005343 | 93.86 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.85 | gold quality |
| aorta | UBERON:0000947 | 93.85 | gold quality |
| body of pancreas | UBERON:0001150 | 93.79 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 93.74 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.72 | gold quality |
| lower esophagus | UBERON:0013473 | 93.72 | gold quality |
| left coronary artery | UBERON:0001626 | 93.62 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.62 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 93.55 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.51 | gold quality |
| saphenous vein | UBERON:0007318 | 93.42 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.40 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 93.40 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.84 |
| E-GEOD-100618 | no | 638.87 |
| E-MTAB-6142 | no | 128.88 |
| E-HCAD-13 | no | 2.80 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting FAM204A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam204a | ENSDARG00000039699 |
| mus_musculus | Fam204a | ENSMUSG00000057858 |
| rattus_norvegicus | Fam204a | ENSRNOG00000009830 |
Protein
Protein identifiers
Protein FAM204A — Q9H8W3 (reviewed: Q9H8W3)
All UniProt accessions (3): Q9H8W3, F2Z2Y3, Q5T374
RefSeq proteins (2): NP_001128144, NP_071346* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037690 | FAM204A | Family |
UniProt features (8 total): compositionally biased region 3, sequence conflict 2, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H8W3-F1 | 71.34 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 102 (showing top):
MYAATNNNNNNNGGC_UNKNOWN, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN, NUYTTEN_EZH2_TARGETS_DN, JOHNSTONE_PARVB_TARGETS_3_DN, NFY_Q6_01, RAO_BOUND_BY_SALL4_ISOFORM_B, DCA_UP.V1_DN, ASH1L_TARGET_GENES, CIITA_TARGET_GENES, NFE2L1_TARGET_GENES, TAF9B_TARGET_GENES, ZIM3_TARGET_GENES, ZNF512B_TARGET_GENES, MIR616_5P, MIR371B_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM204A | TMEM184C | Q9NVA4 | 618 |
| FAM204A | HSF2 | Q03933 | 539 |
| FAM204A | MFAP3L | O75121 | 528 |
| FAM204A | RAB11FIP2 | Q7L804 | 477 |
| FAM204A | C7orf25 | Q9BPX7 | 477 |
| FAM204A | CHCHD3 | Q9NX63 | 456 |
| FAM204A | FAM133B | Q5BKY9 | 437 |
| FAM204A | ANKRD40 | Q6AI12 | 435 |
| FAM204A | NAA10 | P41227 | 434 |
| FAM204A | FAM110B | Q8TC76 | 431 |
| FAM204A | TMEM179 | Q6ZVK1 | 424 |
| FAM204A | SMU1 | Q2TAY7 | 410 |
| FAM204A | HAUS8 | Q9BT25 | 386 |
| FAM204A | EXOC4 | Q96A65 | 366 |
| FAM204A | CLIP3 | Q96DZ5 | 348 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMYD1 | FAM204A | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM204A | SMYD1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| FHL2 | FAM204A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KDM1A | FAM204A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN2 | FAM204A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM177A1 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.530 |
| FXYD1 | GCHFR | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC60 | DCP1B | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC60 | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| S100A6 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| H2AJ | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| SERF2 | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| CRCP | SRC | psi-mi:“MI:0914”(association) | 0.350 |
| PLGRKT | VPS13C | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXN2 | FAM204A | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMYD1 | FAM204A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (32): FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), HAT1 (Affinity Capture-MS), KPNB1 (Affinity Capture-MS), NPEPPS (Affinity Capture-MS), KPNA2 (Affinity Capture-MS), KPNA3 (Affinity Capture-MS), COPG1 (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Two-hybrid), FAM204A (Two-hybrid), FAM204A (Two-hybrid), SPANXN2 (Two-hybrid)
ESM2 similar proteins: A0AUP1, A4II15, A7MCB7, E1C760, F6RRD7, F7AEX0, P14629, P78316, Q1L8X2, Q28DG8, Q2IA00, Q3T071, Q3U155, Q3ZCI6, Q4R6T7, Q4R8R3, Q4R8V8, Q4V7N4, Q5PQS7, Q5R939, Q5RA37, Q5XI65, Q5ZIH9, Q5ZIM6, Q6DFL5, Q6IEG0, Q6PBE2, Q6PII3, Q7SYB2, Q7ZXA8, Q80VN0, Q8C6C7, Q8C9J3, Q8CIL4, Q8IXW5, Q8R3N1, Q8R3N6, Q8VYD3, Q93VM9, Q95JM8
Diamond homologs: Q3ZCI6, Q5R939, Q8C6C7, Q9H8W3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1757 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:118309870:A:AC | donor_gain | 1.0000 |
| 10:118311199:AAACT:A | donor_loss | 1.0000 |
| 10:118311200:AACTC:A | donor_loss | 1.0000 |
| 10:118311201:ACTC:A | donor_loss | 1.0000 |
| 10:118311202:CTCAC:C | donor_loss | 1.0000 |
| 10:118311203:TCACC:T | donor_loss | 1.0000 |
| 10:118311204:CACC:C | donor_loss | 1.0000 |
| 10:118311205:A:C | donor_loss | 1.0000 |
| 10:118311205:AC:A | donor_gain | 1.0000 |
| 10:118311205:ACC:A | donor_gain | 1.0000 |
| 10:118311205:ACCC:A | donor_gain | 1.0000 |
| 10:118311206:C:CG | donor_loss | 1.0000 |
| 10:118311206:CC:C | donor_gain | 1.0000 |
| 10:118311206:CCC:C | donor_gain | 1.0000 |
| 10:118311206:CCCC:C | donor_gain | 1.0000 |
| 10:118311309:CCAAG:C | acceptor_gain | 1.0000 |
| 10:118311310:CAAG:C | acceptor_gain | 1.0000 |
| 10:118311310:CAAGC:C | acceptor_gain | 1.0000 |
| 10:118311311:AAG:A | acceptor_gain | 1.0000 |
| 10:118311312:AG:A | acceptor_gain | 1.0000 |
| 10:118311312:AGCTA:A | acceptor_loss | 1.0000 |
| 10:118311313:GCT:G | acceptor_loss | 1.0000 |
| 10:118311314:C:CC | acceptor_gain | 1.0000 |
| 10:118311315:T:C | acceptor_loss | 1.0000 |
| 10:118311321:T:C | acceptor_gain | 1.0000 |
| 10:118311321:T:TC | acceptor_gain | 1.0000 |
| 10:118326149:CTCA:C | donor_loss | 1.0000 |
| 10:118326150:TCA:T | donor_loss | 1.0000 |
| 10:118326151:CA:C | donor_loss | 1.0000 |
| 10:118326152:A:AC | donor_gain | 1.0000 |
AlphaMissense
1551 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:118310887:C:A | W224C | 1.000 |
| 10:118310887:C:G | W224C | 1.000 |
| 10:118310889:A:G | W224R | 1.000 |
| 10:118310889:A:T | W224R | 1.000 |
| 10:118310878:T:A | K227N | 0.999 |
| 10:118310878:T:G | K227N | 0.999 |
| 10:118310888:C:G | W224S | 0.999 |
| 10:118310905:A:C | F218L | 0.999 |
| 10:118310905:A:T | F218L | 0.999 |
| 10:118310907:A:G | F218L | 0.999 |
| 10:118311209:C:A | W216C | 0.999 |
| 10:118311209:C:G | W216C | 0.999 |
| 10:118311211:A:G | W216R | 0.999 |
| 10:118311211:A:T | W216R | 0.999 |
| 10:118310869:C:A | M230I | 0.998 |
| 10:118310869:C:G | M230I | 0.998 |
| 10:118310869:C:T | M230I | 0.998 |
| 10:118310879:T:A | K227I | 0.998 |
| 10:118310890:T:A | R223S | 0.998 |
| 10:118310890:T:G | R223S | 0.998 |
| 10:118310896:C:A | K221N | 0.998 |
| 10:118310896:C:G | K221N | 0.998 |
| 10:118311292:C:G | A189P | 0.998 |
| 10:118310868:C:G | G231R | 0.997 |
| 10:118310868:C:T | G231R | 0.997 |
| 10:118310875:G:C | S228R | 0.997 |
| 10:118310875:G:T | S228R | 0.997 |
| 10:118310877:T:G | S228R | 0.997 |
| 10:118310880:T:G | K227Q | 0.997 |
| 10:118310891:C:G | R223T | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000021509 (10:118299453 C>A,T), RS1000105366 (10:118299723 T>C), RS1000115220 (10:118299447 T>A,C), RS1000278370 (10:118316720 G>A), RS1000297430 (10:118336618 A>C), RS1000309289 (10:118316366 C>T), RS1000321600 (10:118305619 G>T), RS1000428657 (10:118313558 T>C,G), RS1000477780 (10:118299242 G>C), RS1000600448 (10:118304562 C>T), RS1000610891 (10:118318376 C>T), RS1000645067 (10:118317999 C>A), RS1000668244 (10:118312421 C>T), RS1000670612 (10:118305909 T>C), RS1000827708 (10:118325170 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006858_1 | Leisure-time exercise behaviour (age-stratified) | 1.000000e-07 |
| GCST012322_45 | Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder | 1.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0000483 | exercise |
| EFO:0004530 | triglyceride measurement |
| EFO:0005658 | response to selective serotonin reuptake inhibitor |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| afimoxifene | decreases expression, decreases reaction | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Estrogens | decreases expression, decreases reaction | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Zinc | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.